ARCHIVES

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

This article is from The Cancer Letter archive.

Vol. 34 No. 03 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993

NCI Advisory Group, Other Cancer Meetings

January 30, 1976

NCI CTEP-Approved Trials For the Month of February

February 28, 2014

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007